An Extension Protocol to Evaluate Dose Comparisons of Leucine-Metformin Combinations in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Study NS-0100-01E is an extension of Study NS-01-0100 designed to assess safety and longer
term effect (i.e., additional 8 weeks) of various fixed-dose leucine and metformin
combinations (NS-0100) versus standard metformin monotherapy on glycemic control in subjects
with type 2 diabetes using HbA1c as the primary endpoint.